Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer

L. Garland, L. A. Robinson, Henry Wagner Jr.

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Management of the stage IIIA (N2) patient remains one of the most controversial areas in thoracic oncology. The potential cur-ability of at least some of these patients has encourage the development of more complex, aggressive, and toxic multimodality treatment regimens.

Original languageEnglish (US)
Pages (from-to)69-100
Number of pages32
JournalChest Surgery Clinics of North America
Volume11
Issue number1
Publication statusPublished - Mar 26 2001

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this